Bobak R. Azamian, President/CEO and Board Chair at Tarsus Pharmaceuticals, Inc. (TARS), sold 10,000 shares at $61.24 ($615K) on 2026-06-17, disclosed to the SEC on 2026-06-22.
Scheduled sale ($615k) by President/CEO and Board Chair under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.24 | 4,582 | $281K | 45.6% |
| 2 | $61.81 | 5,418 | $335K | 54.4% |
| Total | $61.55 avg | 10,000 | $615K | 100% |
| Filing → |
| TARS | SELL | 2026-03-19 | $2.4M | — | Filing → |
| TARS | SELL | 2025-12-30 | $944K | — | Filing → |
| TARS | SELL | 2025-09-26 | $332K | — | Filing → |